NVO Stock Summary and Trading Ideas (Novo Nordisk A/S | NYSE:NVO)

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

What symbol and exchange does Novo Nordisk A/S shares trade?

Novo Nordisk A/S trades on the NYSE stock market under the symbol NVO.

What is Novo Nordisk A/S stock price doing today?

As of June 18, 2026, NVO stock price declined to $43.19 with 7,637,676 million shares trading.

What is Novo Nordisk A/S's Beta?

NVO has a beta of 2.10, meaning it tends to be more sensitive to market movements. NVO has a correlation of 0.15 to the broad based SPY ETF.

How much is Novo Nordisk A/S worth?

NVO has a market cap of $191.24 billion. This is considered a Large Cap stock.

How much money does Novo Nordisk A/S make?

Last quarter Novo Nordisk A/S reported $15 billion in Revenue and $1.04 earnings per share. This beat revenue expectation by $4 billion and exceeded earnings estimates by $.17.

What is the highest and lowest price Novo Nordisk A/S traded in the last 3 year period?

In the last 3 years, NVO traded as high as $148.15 and as low as $35.12.

What are the top ETFs holding Novo Nordisk A/S?

The top ETF exchange traded funds that NVO belongs to (by Net Assets): PVAL, PPH, AVDE, PID, WCMI.

Is Novo Nordisk A/S (NVO) a good investment?

NVO has underperformed the market in the last year with a return of -39.4%, while SPY returned +26.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NVO shares. However, NVO has outperformed the market in the last 3 month and 2 week periods, returning +15.7% and +2.8%, while SPY returned +11.6% and -1.0%, respectively. This indicates NVO has been having a stronger performance recently.

What are the support and resistance levels for Novo Nordisk A/S (NVO)?

NVO support price is $42.53 and resistance is $44.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVO shares will trade within this expected range on the day.